Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I

被引:5
|
作者
Yousefi, Maria [1 ]
Sudarsan, Arun Kumar Annan [1 ,2 ]
Gaba, Amit [1 ]
Chelico, Linda [1 ]
机构
[1] Univ Saskatchewan, Coll Med, Dept Biochem Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada
[2] Ctr Commercializat Regenerat Med CCRM, 661 Univ Ave 1002, Toronto, ON M5G 1M1, Canada
来源
VIRUSES-BASEL | 2023年 / 15卷 / 02期
基金
加拿大健康研究院;
关键词
restriction factor; HIV-1; APOBEC3; HEPATITIS-B-VIRUS; CBF-BETA; RESTRICTION; RNA; POLYMORPHISMS; HYPERMUTATION; DIMERIZATION; DEAMINATION; INHIBITION; EVOLUTION;
D O I
10.3390/v15020463
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The seven human APOBEC3 enzymes (APOBEC3A through H, excluding E) are host restriction factors. Most of the APOBEC3 enzymes can restrict HIV-1 replication with different efficiencies. The HIV-1 Vif protein combats APOBEC3-mediated restriction by inducing ubiquitination and degradation in the proteasome. APOBEC3F and APOBEC3G can hetero-oligomerize, which increases their restriction capacity and resistance to Vif. Here we determined if APOBEC3C, APOBEC3F, or APOBEC3G could hetero-oligomerize with APOBEC3H haplotype I. APOBEC3H haplotype I has a short half-life in cells due to ubiquitination and degradation by host proteins, but is also resistant to Vif. We hypothesized that hetero-oligomerization with APOBEC3H haplotype I may result in less Vif-mediated degradation of the interacting APOBEC3 and stabilize APOBEC3H haplotype I, resulting in more efficient HIV-1 restriction. Although we found that all three APOBEC3s could interact with APOBEC3H haplotype I, only APOBEC3F affected APOBEC3H haplotype I by surprisingly accelerating its proteasomal degradation. However, this increased APOBEC3F levels in cells and virions in the absence or presence of Vif and enabled APOBEC3F-mediated restriction of HIV-1 in the presence of Vif. Altogether, the data suggest that APOBEC3 enzymes can co-regulate each other at the protein level and that they cooperate to ensure HIV-1 inactivation rather than evolution.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins
    Wiegand, HL
    Doehle, BP
    Bogerd, HP
    Cullen, BR
    EMBO JOURNAL, 2004, 23 (12): : 2451 - 2458
  • [42] Structural basis of HIV-1 Vif-mediated E3 ligase targeting of host APOBEC3H
    Ito, Fumiaki
    Alvarez-Cabrera, Ana L.
    Kim, Kyumin
    Zhou, Z. Hong
    Chen, Xiaojiang S.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [43] APOBEC3H polymorphisms and susceptibility to HIV-1 infection in an Indian population
    Naruse, Taeko K.
    Sakurai, Daisuke
    Ohtani, Hitoshi
    Sharma, Gaurav
    Sharma, Surendra K.
    Vajpayee, Madhu
    Mehra, Narinder K.
    Kaur, Gurvinder
    Kimura, Akinori
    JOURNAL OF HUMAN GENETICS, 2016, 61 (03) : 263 - 265
  • [44] APOBEC3H polymorphisms and susceptibility to HIV-1 infection in an Indian population
    Taeko K Naruse
    Daisuke Sakurai
    Hitoshi Ohtani
    Gaurav Sharma
    Surendra K Sharma
    Madhu Vajpayee
    Narinder K Mehra
    Gurvinder Kaur
    Akinori Kimura
    Journal of Human Genetics, 2016, 61 : 263 - 265
  • [45] Human cytidine deaminase APOBEC3H restricts HIV-1 replication
    Dang, Ying
    Siew, Lai Mun
    Wang, Xiaojun
    Han, Yanxing
    Lampen, Russell
    Zheng, Yong-Hui
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (17) : 11606 - 11614
  • [46] CBFβ Stabilizes HIV Vif to Counteract APOBEC3 at the Expense of RUNX1 Target Gene Expression
    Kim, Dong Young
    Kwon, Eunju
    Hartley, Paul D.
    Crosby, David C.
    Mann, Sumanjit
    Krogan, Nevan J.
    Gross, John D.
    MOLECULAR CELL, 2013, 49 (04) : 632 - 644
  • [47] APOBEC3 Hypermutations in HIV-1 Infected Cases in Turkey
    Sayan, Murat
    Simsek, Funda
    Ceran, Nurgul
    Dokuzocuz, Basak
    Eraksoy, Haluk
    MIKROBIYOLOJI BULTENI, 2013, 47 (03): : 482 - 492
  • [48] HIV-1 Vif Interaction with APOBEC3 Deaminases and its Characterization by a New Sensitive Assay
    Iris Cadima-Couto
    Nuno Saraiva
    Ana Catarina C. Santos
    Joao Goncalves
    Journal of Neuroimmune Pharmacology, 2011, 6 : 296 - 307
  • [49] Identification of HIV-1 Vif Regions Required for CBF-β Interaction and APOBEC3 Suppression
    Wang, Hong
    Liu, Bin
    Liu, Xin
    Li, Zhaolong
    Yu, Xiao-Fang
    Zhang, Wenyan
    PLOS ONE, 2014, 9 (05):
  • [50] Multiple APOBEC3 Restriction Factors for HIV-1 and One Vif to Rule Them All
    Desimmie, Belete A.
    Delviks-Frankenberrry, Krista A.
    Burdick, Ryan C.
    Qi, DongFei
    Izumi, Taisuke
    Pathak, Vinay K.
    JOURNAL OF MOLECULAR BIOLOGY, 2014, 426 (06) : 1220 - 1245